Follow-Up of Liver Stiffness with Shear Wave Elastography in Chronic Hepatitis C Patients in Sustained Virological Response Augments Clinical Risk Assessment
Abstract
:1. Introduction
2. Materials and Methods
2.1. Patient Population
2.2. Liver Stiffness Measurements with Shear Wave Elastography
2.3. Collection of Laboratory Tests and Clinical Data
2.4. Statistical Analysis
3. Results
3.1. LS Decreases after Successful Antiviral Therapy
3.2. Laboratory Tests Improve in Parallel with LS
3.3. The Risk of Esophageal VNT Decreases in SVR
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Lombardi, A.; Mondelli, M.U. ESCMID Study Group for Viral Hepatitis (ESGVH) Hepatitis C: Is eradication possible? Liver Int. 2019, 39, 416–426. [Google Scholar] [CrossRef] [Green Version]
- Pawlotsky, J.-M.; Negro, F.; Aghemo, A.; Berenguer, M.; Dalgard, O.; Dusheiko, G.; Marra, F.; Puoti, M.; Wedemeyer, H. EASL Recommendations on Treatment of Hepatitis C. J. Hepatol. 2018, 69, 461–511. [Google Scholar] [CrossRef] [Green Version]
- Holmes, A.J.; Rutledge, S.M.; Chung, R.T. Direct-Acting Antiviral Treatment for Hepatitis C. Lancet 2019, 393, 1392–1394. [Google Scholar] [CrossRef]
- Ghany, M.G.; Morgan, T.R.; Panel, A.H.C.G.; Marks, K.M.; Wyles, D.L.; Aronsohn, A.I.; Bhattacharya, D.; Broder, T.; Falade-Nwulia, O.O.; Feld, J.J.; et al. Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases–Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Hepatology 2019, 71, 686–721. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Budai, B.K.; Tóth, A.; Borsos, P.; Frank, V.G.; Shariati, S.; Fejér, B.; Folhoffer, A.; Szalay, F.; Bérczi, V.; Kaposi, P.N. Three-Dimensional CT Texture Analysis of Anatomic Liver Segments can Differentiate between Low-Grade and High-Grade Fibrosis. BMC Med Imaging 2020, 20, 1–11. [Google Scholar] [CrossRef] [PubMed]
- Low, G. General Review of Magnetic Resonance Elastography. World J. Radiol. 2016, 8, 59–72. [Google Scholar] [CrossRef]
- Ferraioli, G.; Tinelli, C.; Bello, B.D.; Zicchetti, M.; Filice, G.; Filice, C.; Liver Fibrosis Study Group. Accuracy of Real-Time Shear Wave Elastography for Assessing Liver Fibrosis in Chronic Hepatitis C: A Pilot Study. Hepatology 2012, 56, 2125–2133. [Google Scholar] [CrossRef]
- Karlas, T.; Pfrepper, C.; Wiegand, J.; Wittekind, C.; Neuschulz, M.; Mössner, J.; Berg, T.; Tröltzsch, M.; Keim, V. Acoustic Radiation Force Impulse Imaging (ARFI) for Non-Invasive Detection of Liver Fibrosis: Examination Standards and Evaluation of Interlobe Differences in Healthy Subjects and Chronic Liver Disease. Scand. J. Gastroenterol. 2011, 46, 1458–1467. [Google Scholar] [CrossRef] [PubMed]
- Bota, S.; Herkner, H.; Sporea, I.; Salzl, P.; Sirli, R.; Neghina, A.M.; Peck-Radosavljevic, M. Meta-Analysis: ARFI Elastography Versus Transient Elastography for the Evaluation of Liver Fibrosis. Liver Int. 2013, 33, 1138–1147. [Google Scholar] [CrossRef]
- Kaposi, P.N.; Unger, Z.; Fejér, B.; Kucsa, A.; Tóth, A.; Folhoffer, A.; Szalay, F.; Bérczi, V. Interobserver Agreement and Diagnostic Accuracy of Shearwave Elastography for the Staging of Hepatitis C Virus-Associated Liver Fibrosis. J. Clin. Ultrasound 2019, 48, 67–74. [Google Scholar] [CrossRef] [PubMed]
- European Association for the Study of the Liver; Asociación Latinoamericana Para el Estudio Del Hígado. EASL-ALEH Clinical Practice Guidelines: Non-Invasive Tests for Evaluation of Liver Disease Severity and Prognosis. J. Hepatol. 2015, 63, 237–264. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chekuri, S.; Nickerson, J.; Bichoupan, K.; Sefcik, R.; Doobay, K.; Chang, S.; DelBello, D.; Harty, A.; Dieterich, U.T.; Perumalswami, P.V.; et al. Liver Stiffness Decreases Rapidly in Response to Successful Hepatitis C Treatment and Then Plateaus. PLoS ONE 2016, 11, e0159413. [Google Scholar] [CrossRef]
- Hézode, C.; Castéra, L.; Roudot-Thoraval, F.; Bouvier-Alias, M.; Rosa, I.; Roulot, D.; Leroy, V.; Mallat, A.; Pawlotsky, J.-M. Liver Stiffness Diminishes with Antiviral Response in Chronic Hepatitis C. Aliment. Pharmacol. Ther. 2011, 34, 656–663. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Libânio, D.; Marinho, R.T. Impact of Hepatitis C Oral Therapy in Portal Hypertension. World J. Gastroenterol. 2017, 23, 4669–4674. [Google Scholar] [CrossRef] [PubMed]
- Attia, D.; Deterding, K.; Cornberg, J.; Gebel, M.J.; Cornberg, M.; Manns, M.P.; Wedemeyer, H.; Potthoff, A. Different Kinetics of Liver Stiffness using Shear Wave Elastography in Patients with Chronic Hepatitis C Infection Treated with Interferon-Free Regimens. Eur. J. Gastroenterol. Hepatol. 2019, 31, 67–74. [Google Scholar] [CrossRef] [PubMed]
- Jacobson, I.M.; Lim, J.K.; Fried, M.W. American Gastroenterological Association Institute Clinical Practice Update—Expert Review: Care of Patients Who Have Achieved a Sustained Virologic Response After Antiviral Therapy for Chronic Hepatitis C Infection. Gastroenterology 2017, 152, 1578–1587. [Google Scholar] [CrossRef] [Green Version]
- De Franchis, R. Expanding Consensus in Portal Hypertension. J. Hepatol. 2015, 63, 743–752. [Google Scholar] [CrossRef] [Green Version]
- Paternostro, R.; Reiberger, T.; Bucsics, T. Elastography-Based Screening for Esophageal Varices in Patients with Advanced Chronic Liver Disease. World J. Gastroenterol. 2019, 25, 308–329. [Google Scholar] [CrossRef] [PubMed]
- Kamath, P.S.; Kim, W.R. The Model for End-Stage Liver Disease (MELD) & Dagger. Hepatology 2007, 45, 797–805. [Google Scholar] [CrossRef]
- Sterling, R.K.; Lissen, E.; Clumeck, N.; Sola, R.; Correa, M.C.; Montaner, J.; Sulkowski, M.S.; Torriani, F.J.; Dieterich, D.T.; Thomas, D.L.; et al. Development of a Simple Noninvasive Index to Predict Significant Fibrosis in Patients with HIV/HCV Coinfection. Hepatology 2006, 43, 1317–1325. [Google Scholar] [CrossRef] [PubMed]
- Pugh, R.N.H.; Murray-Lyon, I.M.; Dawson, J.L.; Pietroni, M.C.; Williams, R. Transection of the Oesophagus for Bleeding Oesophageal Varices. BJS 2005, 60, 646–649. [Google Scholar] [CrossRef]
- Marshall, A.D.; Pawlotsky, J.-M.; Lazarus, J.V.; Aghemo, A.; Dore, G.J.; Grebely, J. The Removal of DAA Restrictions in Europe —One Step Closer to Eliminating HCV as a Major Public Health Threat. J. Hepatol. 2018, 69, 1188–1196. [Google Scholar] [CrossRef] [PubMed]
- D’Ambrosio, R.; Aghemo, A.; Rumi, M.G.; Ronchi, G.; Donato, M.F.; Paradis, V.; Colombo, M.; Bedossa, P. A Morphometric and Immunohistochemical Study to Assess the Benefit of a Sustained Virological Response in Hepatitis C Virus Patients with Cirrhosis. Hepatology 2012, 56, 532–543. [Google Scholar] [CrossRef] [PubMed]
- Ferraioli, G.; Tinelli, C.; Lissandrin, R.; Zicchetti, M.; Bello, B.D.; Filice, G.; Filice, C. Point Shear Wave Elastography Method for Assessing Liver Stiffness. World J. Gastroenterol. 2014, 20, 4787–4796. [Google Scholar] [CrossRef] [PubMed]
- Tachi, Y.; Hirai, T.; Kojima, Y.; Ishizu, Y.; Honda, T.; Kuzuya, T.; Hayashi, K.; Ishigami, M.; Goto, H. Liver Stiffness Reduction Correlates with Histological Characteristics of Hepatitis C Patients with Sustained Virological Response. Liver Int. 2017, 38, 59–67. [Google Scholar] [CrossRef]
- Facciorusso, A.; Del Prete, V.; Turco, A.; Buccino, R.V.; Nacchiero, M.C.; Muscatiello, N. Long-Term Liver Stiffness Assessment in Hepatitis C Virus Patients Undergoing Antiviral Therapy: Results From a 5-year Cohort Study. J. Gastroenterol. Hepatol. 2018, 33, 942–949. [Google Scholar] [CrossRef]
- Bruno, S.; Crosignani, A.; Facciotto, C.; Rossi, S.; Roffi, L.; Redaelli, A.; De Franchis, R.; Almasio, P.L.; Maisonneuve, P. Sustained Virologic Response Prevents the Development of Esophageal Varices in Compensated, Child-Pugh Class A Hepatitis C Virus-Induced Cirrhosis. A 12-Year Prospective Follow-Up Study. Hepatology 2010, 51, 2069–2076. [Google Scholar] [CrossRef]
- Mallet, V.; Gilgenkrantz, H.; Serpaggi, J.; Verkarre, V.; Vallet-Pichard, A.; Fontaine, H.; Pol, S. Brief Communication: The Relationship of Regression of Cirrhosis to Outcome in Chronic Hepatitis C. Ann. Intern. Med. 2008, 149, 399–403. [Google Scholar] [CrossRef]
- Nagaoki, Y.; Aikata, H.; Nakano, N.; Shinohara, F.; Nakamura, Y.; Hatooka, M.; Morio, K.; Kan, H.; Fujino, H.; Kobayashi, T.; et al. Development of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Infection Who Achieved Sustained Virological Response Following Interferon Therapy: A Large-Scale, Long-Term Cohort Study. J. Gastroenterol. Hepatol. 2015, 31, 1009–1015. [Google Scholar] [CrossRef] [PubMed]
Baseline | EOT48w 1 | p-Value 2 | Odds-Ratio | |
---|---|---|---|---|
LS | 2.59 ± 0.89 m/s | 1.90 ± 0.50 m/s | p < 0.001 | NA |
METAVIR 3 | p < 0.028 | NA | ||
F0/1 | 2 (5.7%) | 9 (25.7%) | p < 0.045 | 5.71 (1.13–28.74) |
F2 | 1 (2.8%) | 2 (5.7%) | p < 1.00 | 2.06 (0.18–23.82) |
F3 | 7 (20%) | 10 (28.6%) | p < 0.578 | 1.60 (0.53–4.83) |
F4 | 25 (71.4%) | 14 (40%) | p < 0.015 | 0.27 (0.09–0.72) |
Baseline | EOT48w 1 | p-Value 2 | |
---|---|---|---|
AST (IU/L) | 75.7 | 27.7 | p < 0.019 |
ALT (IU/L) | 92.7 | 25 | p < 0.001 |
GGT (IU/L) | 137.1 | 54.1 | p < 0.001 |
TBILL (µmol/L) | 20.5 | 16.9 | p < 0.030 |
ALB (g/L) | 41.3 | 43.8 | p < 0.001 |
CRE (µmol/L) | 70.7 | 74 | p < 0.023 |
Na (mmol/L) | 138.1 | 139.6 | p < 0.104 |
INR | 1.2 | 1.3 | p < 0.288 |
PLT (109/L) | 168.5 | 180 | p < 0.249 |
Baseline | EOT48w 1 | p-Value 2 | Odds Ratio | |
---|---|---|---|---|
Ascites | 2 (6%) | 1 (3%) | p < 1.00 | 0.49 (0.04–5.61) |
FIB4 score 3 | 3.51 ± 2.24 | 2.04 ± 1.12 | p < 0.018 | NA |
VNT 3 | 15 (42%) | 4 (11%) | p < 0.007 | 0.17 (0.05–0.59) |
CTP class 3 | ||||
A | 30 (86%) | 34 (97%) | p < 0.127 | 5.67 (0.63–51.27) |
B | 5 (14%) | 1 (3%) | 0.18 (0.02–1.60) | |
C | 0 | 0 | NA | NA |
MELD score 3 | ||||
<10 | 25 (71%) | 25 (71%) | p < 1.00 | 1.00 (0.35–2.82) |
<20 | 8 (23%) | 9 (26%) | p < 1.00 | 0.86 (0.29–2.56) |
<25 | 2 (6%) | 1 (3%) | p < 0.619 | 2.06 (0.18–23.82) |
≥25 | 0 | 0 | NA | NA |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Folhoffer, A.; Rónaszéki, A.D.; Budai, B.K.; Borsos, P.; Orbán, V.; Győri, G.; Szalay, F.; Kaposi, P.N. Follow-Up of Liver Stiffness with Shear Wave Elastography in Chronic Hepatitis C Patients in Sustained Virological Response Augments Clinical Risk Assessment. Processes 2021, 9, 753. https://doi.org/10.3390/pr9050753
Folhoffer A, Rónaszéki AD, Budai BK, Borsos P, Orbán V, Győri G, Szalay F, Kaposi PN. Follow-Up of Liver Stiffness with Shear Wave Elastography in Chronic Hepatitis C Patients in Sustained Virological Response Augments Clinical Risk Assessment. Processes. 2021; 9(5):753. https://doi.org/10.3390/pr9050753
Chicago/Turabian StyleFolhoffer, Anikó, Aladár D. Rónaszéki, Bettina K. Budai, Petra Borsos, Vince Orbán, Gabriella Győri, Ferenc Szalay, and Pál N. Kaposi. 2021. "Follow-Up of Liver Stiffness with Shear Wave Elastography in Chronic Hepatitis C Patients in Sustained Virological Response Augments Clinical Risk Assessment" Processes 9, no. 5: 753. https://doi.org/10.3390/pr9050753